HLA variants related to primary sclerosing cholangitis influence rejection after liver transplantation

World Journal of Gastroenterology

Volumn 20, Issue 14, 2014, Pages 3986-4000

  Fosby, Bjarte ^a,b   Næss, Sigrid ^a,b,c   Hov, Johannes R ^a,b,c   Traherne, James ^d   Boberg, Kirsten M ^a,b,c   Trowsdale, John ^d   Foss, Aksel ^a,b   Line, Pål Dag ^a   Franke, Andre ^e   Melum, Espen ^a,b,c   Scott, Helge ^a,c   Karlsen, Tom H ^a,c  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e UNIVERSITY OF KIEL   (Germany)

Author keywords

Acute rejection; Human leukocyte antigen; Killer immunoglobulin like receptor; Liver transplantation; Primary sclerosing cholangitis

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN; CD57 ANTIGEN; CYCLOSPORIN; HLA ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DRB1 ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS4; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL1; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; B LYMPHOCYTE; CELL INFILTRATION; CONTROLLED STUDY; DRUG DOSE REDUCTION; FEMALE; GENETIC ASSOCIATION; GENOTYPE; GENOTYPING TECHNIQUE; HLA MATCHING; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PRIMARY SCLEROSING CHOLANGITIS; RETROSPECTIVE STUDY; T LYMPHOCYTE; END STAGE LIVER DISEASE; GENETICS; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOLOGY; MIDDLE AGED; RISK FACTOR; SCLEROSING CHOLANGITIS; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ALLELES; CHOLANGITIS, SCLEROSING; END STAGE LIVER DISEASE; FEMALE; GENOTYPE; GRAFT REJECTION; GRAFT SURVIVAL; HLA ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RECEPTORS, KIR; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84898421096     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i14.3986     Document Type: Article

References (80)

1. Klein KB, Stafinski TD, Menon D. Predicting survival after liver transplantation based on pre-transplant MELD score: a systematic review of the literature. PLoS One 2013; 8: e80661 [PMID: 24349010 DOI: 10.1371/journal.pone.0080661]
2. Farges O, Saliba F, Farhamant H, Samuel D, Bismuth A, Reynes M, Bismuth H. Incidence of rejection and infection after liver transplantation as a function of the primary disease: possible influence of alcohol and polyclonal immunoglobulins. Hepatology 1996; 23: 240-248 [PMID: 8591847 DOI: 10.1053/jhep.1996.v23]
3. Bathgate AJ, Pravica V, Perrey C, Therapondos G, Plevris JN, Hayes PC, Hutchinson IV. The effect of polymorphisms in tumor necrosis factor-alpha, interleukin-10, and transforming growth factor-beta1 genes in acute hepatic allograft rejection. Transplantation 2000; 69: 1514-1517 [PMID: 10798783 DOI: 10.1097/00007890-20000415000054]
4. Shaked A, Ghobrial RM, Merion RM, Shearon TH, Emond JC, Fair JH, Fisher RA, Kulik LM, Pruett TL, Terrault NA. Incidence and severity of acute cellular rejection in recipients undergoing adult living donor or deceased donor liver transplantation. Am J Transplant 2009; 9: 301-308 [PMID: 19120082 DOI: 10.1111/j.1600-6143.2008.02487.x]
5. Fosby B, Karlsen TH, Melum E. Recurrence and rejection in liver transplantation for primary sclerosing cholangitis. World J Gastroenterol 2012; 18: 1-15 [PMID: 22228965 DOI: 10.3748/wjg.v18.i1.1]
6. Neuberger J. Incidence, timing, and risk factors for acute and chronic rejection. Liver Transpl Surg 1999; 5: S30-S36 [PMID: 10431015 DOI: 10.1053/JTLS005s00030]
7. Wiesner RH, Demetris AJ, Belle SH, Seaberg EC, Lake JR, Zetterman RK, Everhart J, Detre KM. Acute hepatic allograft rejection: incidence, risk factors, and impact on outcome. Hepatology 1998; 28: 638-645 [PMID: 9731552 DOI: 10.1002/ hep.510280306]
8. Burra P, Senzolo M, Adam R, Delvart V, Karam V, Germani G, Neuberger J. Liver transplantation for alcoholic liver disease in Europe: a study from the ELTR (European Liver Transplant Registry). Am J Transplant 2010; 10: 138-148 [PMID: 19951276 DOI: 10.1111/j.1600-6143.2009.02869.x]
9. Opelz G, Wujciak T, Döhler B, Scherer S, Mytilineos J. HLA compatibility and organ transplant survival. Collaborative Transplant Study. Rev Immunogenet 1999; 1: 334-342 [PMID: 11256424]
10. Neuberger JM, Adams DH. Is HLA matching important for liver transplantation? J Hepatol 1990; 11: 1-4 [PMID: 2204657 DOI: 10.1016/0168-8278(90)90262-P]
11. Nikaein A, Backman L, Jennings L, Levy MF, Goldstein R, Gonwa T, Stone MJ, Klintmalm G. HLA compatibility and liver transplant outcome. Improved patient survival by HLA and cross-matching. Transplantation 1994; 58: 786-792 [PMID: 7940711 DOI: 10.1016/0198-8859(94)91670-5]
12. Doran TJ, Geczy AF, Painter D, McCaughan G, Sheil AG, Süsal C, Opelz G. A large, single center investigation of the immunogenetic factors affecting liver transplantation. Transplantation 2000; 69: 1491-1498 [PMID: 10798776 DOI: 10.1097/00007890-200004150-00047]
13. Alexander J, Lord JD, Yeh MM, Cuevas C, Bakthavatsalam R, Kowdley KV. Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl 2008; 14: 245-251 [PMID: 18236405 DOI: 10.1002/lt.21394]
14. Jeyarajah DR, Netto GJ, Lee SP, Testa G, Abbasoglu O, Husberg BS, Levy MF, Goldstein RM, Gonwa TA, Tillery GW, Crippin JS, Klintmalm GB. Recurrent primary sclerosing cholangitis after orthotopic liver transplantation: is chronic rejection part of the disease process? Transplantation 1998; 66: 1300-1306 [PMID: 9846512 DOI: 10.1097/00007890- 199811270-00006]
15. Brandsaeter B, Schrumpf E, Bentdal O, Brabrand K, Smith HJ, Abildgaard A, Clausen OP, Bjoro K. Recurrent primary sclerosing cholangitis after liver transplantation: a magnetic resonance cholangiography study with analyses of predictive factors. Liver Transpl 2005; 11: 1361-1369 [PMID: 16184522 DOI: 10.1002/lt.20444]
16. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 2005; 5: 201-214 [PMID: 15719024 DOI: 10.1038/nri1570]
17. Vivier E, Anfossi N. Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future. Nat Rev Immunol 2004; 4: 190-198 [PMID: 15039756 DOI: 10.1038/nri1306]
18. Vilches C, Parham P. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol 2002; 20: 217-251 [PMID: 11861603 DOI: 10.1146/annurev. immunol.20.092501.134942]
19. Moroso V, van der Meer A, Tilanus HW, Kazemier G, van der Laan LJ, Metselaar HJ, Joosten I, Kwekkeboom J. Donor and recipient HLA/KIR genotypes do not predict liver transplantation outcome. Transpl Int 2011; 24: 932-942 [PMID: 21672051 DOI: 10.1111/j.1432-2277.2011.01286.x]
20. Tran TH, Middleton D, Döhler B, Scherer S, Meenagh A, Sleator C, Opelz G. Reassessing the impact of donor HLA-C genotype on long-term liver transplant survival. Am J Transplant 2009; 9: 1674-1678 [PMID: 19392983 DOI: 10.1111/ j.1600-6143.2009.02609.x]
21. Hanvesakul R, Spencer N, Cook M, Gunson B, Hathaway M, Brown R, Nightingale P, Cockwell P, Hubscher SG, Adams DH, Moss P, Briggs D. Donor HLA-C genotype has a profound impact on the clinical outcome following liver transplantation. Am J Transplant 2008; 8: 1931-1941 [PMID: 18671674 DOI: 10.1111/j.1600-6143.2008.02341.x]
22. Moya-Quiles MR, Alvarez R, Miras M, Gomez-Mateo J, Lopez-Alvarez MR, Marin-Moreno I, Martínez-Barba E, Sanchez-Mozo MP, Gomez M, Arnal F, Sanchez-Bueno F, Marin LA, Garcia-Alonso AM, Minguela A, Muro M, Parrilla P, Alonso C, Alvarez-López MR. Impact of recipient HLA-C in liver transplant: a protective effect of HLA-Cw*07 on acute rejection. Hum Immunol 2007; 68: 51-58 [PMID: 17207712 DOI: 10.1016/j.humimm.2006.10.009]
23. Bishara A, Brautbar C, Zamir G, Eid A, Safadi R. Impact of HLA-C and Bw epitopes disparity on liver transplantation outcome. Hum Immunol 2005; 66: 1099-1105 [PMID: 16571410 DOI: 10.1016/j.humimm.2005.10.016]
24. Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A, Posati S, Rogaia D, Frassoni F, Aversa F, Martelli MF, Velardi A. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002; 295: 2097-2100 [PMID: 11896281 DOI: 10.1126/science. 1068440]
25. Cook MA, Milligan DW, Fegan CD, Darbyshire PJ, Mahendra P, Craddock CF, Moss PA, Briggs DC. The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia. Blood 2004; 103: 1521-1526 [PMID: 14504099 DOI: 10.1182/blood-2003-02-0438]
26. Hsu KC, Gooley T, Malkki M, Pinto-Agnello C, Dupont B, Bignon JD, Bornhäuser M, Christiansen F, Gratwohl A, Morishima Y, Oudshoorn M, Ringden O, van Rood JJ, Petersdorf E. KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy. Biol Blood Marrow Transplant 2006; 12: 828-836 [PMID: 16864053 DOI: 10.1016/j.bbmt.2006.04.008]
27. Fischer JC, Ottinger H, Ferencik S, Sribar M, Punzel M, Beelen DW, Schwan MA, Grosse-Wilde H, Wernet P, Uhrberg M. Relevance of C1 and C2 epitopes for hemopoietic stem cell transplantation: role for sequential acquisition of HLA-C-specific inhibitory killer Ig-like receptor. J Immunol 2007; 178: 3918-3923 [PMID: 17339492]
28. Sheil AG, Thompson JF, McCaughan GW, Dorney SF, Stephen MS, Shun A, Bookallil MJ, Isai H, McDonald J, Harrison VL. Determinants of successful liver transplantation. Transplant Proc 1990; 22: 2144-2145 [PMID: 2219324]
29. Melum E, Franke A, Schramm C, Weismüller TJ, Gotthardt DN, Offner FA, Juran BD, Laerdahl JK, Labi V, Björnsson E, Weersma RK, Henckaerts L, Teufel A, Rust C, Ellinghaus E, Balschun T, Boberg KM, Ellinghaus D, Bergquist A, Sauer P, Ryu E, Hov JR, Wedemeyer J, Lindkvist B, Wittig M, Porte RJ, Holm K, Gieger C, Wichmann HE, Stokkers P, Ponsioen CY, Runz H, Stiehl A, Wijmenga C, Sterneck M, Vermeire S, Beuers U, Villunger A, Schrumpf E, Lazaridis KN, Manns MP, Schreiber S, Karlsen TH. Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci. Nat Genet 2011; 43: 17-19 [PMID: 21151127 DOI: 10.1038/ng.728]
30. Moloney MM, Thomson LJ, Strettell MJ, Williams R, Donaldson PT. Human leukocyte antigen-C genes and susceptibility to primary sclerosing cholangitis. Hepatology 1998; 28: 660-662 [PMID: 9731555 DOI: 10.1002/hep.510280309]
31. Wiencke K, Karlsen TH, Boberg KM, Thorsby E, Schrumpf E, Lie BA, Spurkland A. Primary sclerosing cholangitis is associated with extended HLA-DR3 and HLA-DR6 haplotypes. Tissue Antigens 2007; 69: 161-169 [PMID: 17257319 DOI: 10.1111/j.1399-0039.2006.00738.x]
32. Donaldson PT, Norris S. Evaluation of the role of MHC class II alleles, haplotypes and selected amino acid sequences in primary sclerosing cholangitis. Autoimmunity 2002; 35: 555-564 [PMID: 12765483 DOI: 10.1080/089169302100005409 3]
33. Leidenius MH, Koskimies SA, Kellokumpu IH, Höckerstedt KA. HLA antigens in ulcerative colitis and primary sclerosing cholangitis. APMIS 1995; 103: 519-524 [PMID: 7576567 DOI: 10.1111/j1699-0463.1995.tb01400.x]
34. Karlsen TH, Boberg KM, Olsson M, Sun JY, Senitzer D, Bergquist A, Schrumpf E, Thorsby E, Lie BA. Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis. J Hepatol 2007; 46: 899-906 [PMID: 17383044 DOI: 10.1016/j.jhep.2007.01.032]
35. Hov JR, Lleo A, Selmi C, Woldseth B, Fabris L, Strazzabosco M, Karlsen TH, Invernizzi P. Genetic associations in Italian primary sclerosing cholangitis: heterogeneity across Europe defines a critical role for HLA-C. J Hepatol 2010; 52: 712-717 [PMID: 20347497 DOI: 10.1016/j.jhep.2009.11.029]
36. Karlsen TH, Schrumpf E, Boberg KM. Update on primary sclerosing cholangitis. Dig Liver Dis 2010; 42: 390-400 [PMID: 20172772 DOI: 10.1016/j.dld.2010.01.011]
37. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 1997; 25: 658-663 [PMID: 9049215 DOI: 10.1002/hep.510250328]
38. Jiang W, Johnson C, Jayaraman J, Simecek N, Noble J, Moffatt MF, Cookson WO, Trowsdale J, Traherne JA. Copy number variation leads to considerable diversity for B but not A haplotypes of the human KIR genes encoding NK cell receptors. Genome Res 2012; 22: 1845-1854 [PMID: 22948769 DOI: 10.1101/gr.137976.112]
39. Khakoo SI, Thio CL, Martin MP, Brooks CR, Gao X, Astemborski J, Cheng J, Goedert JJ, Vlahov D, Hilgartner M, Cox S, Little AM, Alexander GJ, Cramp ME, O'Brien SJ, Rosenberg WM, Thomas DL, Carrington M. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 2004; 305: 872-874 [PMID: 15297676 DOI: 10.1126/ science.1097670]
40. Parham P. Immunology. NK cells lose their inhibition. Science 2004; 305: 786-787 [PMID: 15297654 DOI: 10.1126/science. 1102025]
41. Legaz I, López-Álvarez MR, Campillo JA, Moya-Quiles MR, Bolarín JM, de la Peña J, Salgado G, Gimeno L, García-Alonso AM, Muro M, Miras M, Alonso C, Álvarez-López MR, Minguela A. KIR gene mismatching and KIR/C ligands in liver transplantation: consequences for short-term liver allograft injury. Transplantation 2013; 95: 1037-1044 [PMID: 23478359 DOI: 10.1097/TP.0b013e318286486c]
42. Moya-Quiles MR, Muro M, Torío A, Sánchez-Bueno F, Miras M, Marín L, García-Alonso AM, Parrilla P, Dausset J, Alvarez-López MR. Human leukocyte antigen-C in shortand long-term liver graft acceptance. Liver Transpl 2003; 9: 218-227 [PMID: 12619017 DOI: 10.1053/jlts.2003.50043]
43. Liu JZ, Hov JR, Folseraas T, Ellinghaus E, Rushbrook SM, Doncheva NT, Andreassen OA, Weersma RK, Weismüller TJ, Eksteen B, Invernizzi P, Hirschfield GM, Gotthardt DN, Pares A, Ellinghaus D, Shah T, Juran BD, Milkiewicz P, Rust C, Schramm C, Müller T, Srivastava B, Dalekos G, Nöthen MM, Herms S, Winkelmann J, Mitrovic M, Braun F, Ponsioen CY, Croucher PJ, Sterneck M, Teufel A, Mason AL, Saarela J, Leppa V, Dorfman R, Alvaro D, Floreani A, Onengut-Gumuscu S, Rich SS, Thompson WK, Schork AJ, Næss S, Thomsen I, Mayr G, König IR, Hveem K, Cleynen I, Gutierrez-Achury J, Ricaño-Ponce I, van Heel D, Björnsson E, Sandford RN, Durie PR, Melum E, Vatn MH, Silverberg MS, Duerr RH, Padyukov L, Brand S, Sans M, Annese V, Achkar JP, Boberg KM, Marschall HU, Chazouillères O, Bowlus CL, Wijmenga C, Schrumpf E, Vermeire S, Albrecht M, Rioux JD, Alexander G, Bergquist A, Cho J, Schreiber S, Manns MP, Färkkilä M, Dale AM, Chapman RW, Lazaridis KN, Franke A, Anderson CA, Karlsen TH. Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis. Nat Genet 2013; 45: 670-675 [PMID: 23603763 DOI: 10.1038/ng.2616]
44. Price P, Witt C, Allcock R, Sayer D, Garlepp M, Kok CC, French M, Mallal S, Christiansen F. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol Rev 1999; 167: 257-274 [PMID: 10319267 DOI: 10.1111/j.1600-065x.1999. tb01398.x]
45. Candore G, Lio D, Colonna Romano G, Caruso C. Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: effect of multiple gene interactions. Autoimmun Rev 2002; 1: 29-35 [PMID: 12849055 DOI: 10.1016/ S1568-9972(01)00004-0]
46. Schrumpf E, Fausa O, Førre O, Dobloug JH, Ritland S, Thorsby E. HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease. Scand J Gastroenterol 1982; 17: 187-191 [PMID: 6982501 DOI: 10.3109/00365528209182038]
47. Degli-Esposti MA, Leaver AL, Christiansen FT, Witt CS, Abraham LJ, Dawkins RL. Ancestral haplotypes: conserved population MHC haplotypes. Hum Immunol 1992; 34: 242-252 [PMID: 1464552 DOI: 10.1016/0198-8859(92)90023-G]
48. Doran TJ, Derley L, Chapman J, McCaughan G, Painter D, Dorney S, Sheil AG. Severity of liver transplantation rejection is associated with recipient HLA type. Transplant Proc 1992; 24: 192-193 [PMID: 1539240]
49. Forsberg B, Ekberg H, Johnson U. Influence of recipient's HLA type on the outcome of renal transplantation. Transplant Proc 1992; 24: 2463-2465 [PMID: 1465832]
50. Futagawa Y, Terasaki PI. Effect of primary diseases. Clin Transpl 2003: 419-431 [PMID: 15387126]
51. Undlien DE, Lie BA, Thorsby E. HLA complex genes in type 1 diabetes and other autoimmune diseases. Which genes are involved? Trends Genet 2001; 17: 93-100 [PMID: 11173119 DOI: 10.1016/S0168-9525(00)02180-6]
52. Slavcheva E, Albanis E, Jiao Q, Tran H, Bodian C, Knight R, Milford E, Schiano T, Tomer Y, Murphy B. Cytotoxic T-lymphocyte antigen 4 gene polymorphisms and susceptibility to acute allograft rejection. Transplantation 2001; 72: 935-940 [PMID: 11571462 DOI: 10.1097/00007890-200109150-00032]
53. Perkins JD. The influence of CTLA-4 gene polymorphisms on liver transplant outcomes. Liver Transpl 2006; 12: 1552-1553 [PMID: 17004266 DOI: 10.1002/lt.20923]
54. Tapirdamaz O, Pravica V, Metselaar HJ, Hansen B, Moons L, van Meurs JB, Hutchinson IV, Shaw J, Agarwal K, Adams DH, Day CP, Kwekkeboom J. Polymorphisms in the T cell regulatory gene cytotoxic T lymphocyte antigen 4 influence the rate of acute rejection after liver transplantation. Gut 2006; 55: 863-868 [PMID: 16299026 DOI: 10.1136/ gut.2005.080937]
55. Zhernakova A, van Diemen CC, Wijmenga C. Detecting shared pathogenesis from the shared genetics of immunerelated diseases. Nat Rev Genet 2009; 10: 43-55 [PMID: 19092835 DOI: 10.1038/nrg2489]
56. Cortes A, Brown MA. Promise and pitfalls of the Immunochip. Arthritis Res Ther 2011; 13: 101 [PMID: 21345260 DOI: 10.1186/ar3204]
57. McCarthy MI, Abecasis GR, Cardon LR, Goldstein DB, Little J, Ioannidis JP, Hirschhorn JN. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet 2008; 9: 356-369 [PMID: 18398418 DOI: 10.1038/nrg2344]
58. Colhoun HM, McKeigue PM, Davey Smith G. Problems of reporting genetic associations with complex outcomes. Lancet 2003; 361: 865-872 [PMID: 12642066 DOI: 10.1016/ S0140-6736(03)12715-8]
59. Warlé MC, Metselaar HJ, Hop WC, Tilanus HW. Cytokine gene polymorphisms and acute liver graft rejection: a metaanalysis. Liver Transpl 2005; 11: 19-26 [PMID: 15690532 DOI: 10.1002/lt.20316]
60. Turner D, Grant SC, Yonan N, Sheldon S, Dyer PA, Sinnott PJ, Hutchinson IV. Cytokine gene polymorphism and heart transplant rejection. Transplantation 1997; 64: 776-779 [PMID: 9311720 DOI: 10.1097/00007890-199709150-00021]
61. Poole KL, Gibbs PJ, Evans PR, Sadek SA, Howell WM. Influence of patient and donor cytokine genotypes on renal allograft rejection: evidence from a single centre study. Transpl Immunol 2001; 8: 259-265 [PMID: 11316069 DOI: 10.1016/S0966-3274(01)00030-2]
62. Sankaran D, Asderakis A, Ashraf S, Roberts IS, Short CD, Dyer PA, Sinnott PJ, Hutchinson IV. Cytokine gene polymorphisms predict acute graft rejection following renal transplantation. Kidney Int 1999; 56: 281-288 [PMID: 10411704 DOI: 10.1046/j.1523-1755.1999.00536.x]
63. Hutchings A, Guay-Woodford L, Thomas JM, Young CJ, Purcell WM, Pravica V, Perrey C, Hutchinson IV, Benfield MR. Association of cytokine single nucleotide polymorphisms with B7 costimulatory molecules in kidney allograft recipients. Pediatr Transplant 2002; 6: 69-77 [PMID: 11906646 DOI: 10.1034/J.1399-3046.2002.10444.x]
64. Hackstein H, Klüter H, Fricke L, Hoyer J, Bein G. The IL-4 receptor alpha-chain variant Q576R is strongly associated with decreased kidney allograft survival. Tissue Antigens 1999; 54: 471-477 [PMID: 10599886 DOI: 10.1034/J.1399-0039.1999.540504. x]
65. Müller-Steinhardt M, Härtel C, Müller B, Kirchner H, Fricke L. The interleukin-6 -174promoter polymorphism is associated with long-term kidney allograft survival. Kidney Int 2002; 62: 1824-1827 [PMID: 12371985 DOI: 10.1046/ j.1523-1755.2002.00609.x]
66. Marshall SE, McLaren AJ, McKinney EF, Bird TG, Haldar NA, Bunce M, Morris PJ, Welsh KI. Donor cytokine genotype influences the development of acute rejection after renal transplantation. Transplantation 2001; 71: 469-476 [PMID: 11233912 DOI: 10.1097/00007890-200102150-00022]
67. Abdi R, Tran TB, Sahagun-Ruiz A, Murphy PM, Brenner BM, Milford EL, McDermott DH. Chemokine receptor polymorphism and risk of acute rejection in human renal transplantation. J Am Soc Nephrol 2002; 13: 754-758 [PMID: 11856781]
68. Steinmetz OM, Fischereder M, Weiss M, Helmchen U, Stahl RA, Panzer U. Acute cellular allograft rejection in homozygous CCR 5 Delta32 patients after renal transplantation. Transplantation 2007; 84: 559-561 [PMID: 17713445 DOI: 10.1097/01.tp.0000279004.60372.ef]
69. Fischereder M, Luckow B, Hocher B, Wüthrich RP, Rothenpieler U, Schneeberger H, Panzer U, Stahl RA, Hauser IA, Budde K, Neumayer H, Krämer BK, Land W, Schlöndorff D. CC chemokine receptor 5 and renal-transplant survival. Lancet 2001; 357: 1758-1761 [PMID: 11403814 DOI: 10.1016/ S0140-6736(00)04898-4]
70. McLaren AJ, Marshall SE, Haldar NA, Mullighan CG, Fuggle SV, Morris PJ, Welsh KI. Adhesion molecule polymorphisms in chronic renal allograft failure. Kidney Int 1999; 55: 1977-1982 [PMID: 10231462 DOI: 10.1046/j.1523-1755.1999.00427.x]
71. Borozdenkova S, Smith J, Marshall S, Yacoub M, Rose M. Identification of ICAM-1 polymorphism that is associated with protection from transplant associated vasculopathy after cardiac transplantation. Hum Immunol 2001; 62: 247-255 [PMID: 11250042 DOI: 10.1016/S0198-8859(01)00208-7]
72. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS, Manolio TA. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA 2009; 106: 9362-9367 [PMID: 19474294 DOI: 10.1073/pnas.0903103106]
73. Todd JA, Bell JI, McDevitt HO. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 1987; 329: 599-604 [PMID: 3309680 DOI: 10.1038/329599a0]
74. Donaldson P, Underhill J, Doherty D, Hayllar K, Calne R, Tan KC, O'Grady J, Wight D, Portmann B, Williams R. Influence of human leukocyte antigen matching on liver allograft survival and rejection: "the dualistic effect". Hepatology 1993; 17: 1008-1015 [PMID: 8514248 DOI: 10.1016/0270-9 139(93)90115-4]
75. Vilches C, Parham P. Do NK-cell receptors and alloreactivity affect solid organ transplantation? Transpl Immunol 2006; 17: 27-30 [PMID: 17157210 DOI: 10.1016/j.trim.2006.09.022]
76. Uehara S, Chase CM, Kitchens WH, Rose HS, Colvin RB, Russell PS, Madsen JC. NK cells can trigger allograft vasculopathy: the role of hybrid resistance in solid organ allografts. J Immunol 2005; 175: 3424-3430 [PMID: 16116237]
77. Kitchens WH, Uehara S, Chase CM, Colvin RB, Russell PS, Madsen JC. The changing role of natural killer cells in solid organ rejection and tolerance. Transplantation 2006; 81: 811-817 [PMID: 16570001 DOI: 10.1097/01.tp.0000202844.33794.0e]
78. Hsieh CL, Obara H, Ogura Y, Martinez OM, Krams SM. NK cells and transplantation. Transpl Immunol 2002; 9: 111-114 [PMID: 12180816 DOI: 10.1016/S0966-3274(02)00033-3]
79. Hashimoto E, Lindor KD, Homburger HA, Dickson ER, Czaja AJ, Wiesner RH, Ludwig J. Immunohistochemical characterization of hepatic lymphocytes in primary biliary cirrhosis in comparison with primary sclerosing cholangitis and autoimmune chronic active hepatitis. Mayo Clin Proc 1993; 68: 1049-1055 [PMID: 8231268 DOI: 10.1016/ S0025-6196(12)60897-0]
80. Hata K, Van Thiel DH, Herberman RB, Whiteside TL. Phenotypic and functional characteristics of lymphocytes isolated from liver biopsy specimens from patients with active liver disease. Hepatology 1992; 15: 816-823 [PMID: 1568723 DOI: 10.1002/hep]